Curcumin Oligosaccharides (Gluco-oligosaccharides) Penetrate the Blood-Brain Barrier in Mouse Brain: Glycoside (Polysaccharide) Modification Approach for Brain Drug Delivery Across the Blood-Brain Barrier and Tumor Drug Delivery

被引:5
|
作者
Hamada, Hiroki [1 ]
Nakayama, Takahiro [2 ]
Shimoda, Kei [3 ]
Matsuura, Nobuyasu [2 ]
Hamada, Hatsuyuki [4 ]
Iwaki, Takafumi [5 ]
Kiriake, Yuya [6 ]
Saikawa, Tomohiro [7 ]
机构
[1] Okayama Univ Sci, Fac Sci, Dept Life Sci, Okayama, Japan
[2] Kyorin Univ, Sch Med, Dept Med Physiol, Tokyo, Japan
[3] Oita Univ, Fac Med, Dept Biomed Chem, Oita, Japan
[4] Natl Inst Fitness & Sports Kanoya, Sch Phys Educ, Kagoshima, Japan
[5] Oita Univ, Fac Med, Dept Biophys, Oita, Japan
[6] Yamaguchi Univ, Fac Med & Hlth Sci, Yamaguchi, Japan
[7] Junshin Gakuen Univ, Dept Nursing, Fukuoka, Japan
关键词
drug delivery technique; blood-brain barrier; curcumin glucooligosaccharide; glycosylation; brain drug delivery; tumor drug delivery;
D O I
10.1177/1934578X20953653
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In order to expand our drug delivery technique by glycosylation of chemical into brain delivery, it was demonstrated that oligosaccharide and monosaccharide modifications of curcumin enhanced its crossing ability of the blood-brain barrier (BBB) in mice. The brain sample prepared by glycosidase-catalyzed hydrolysis of brain tissue homogenates of mice, to which curcumin gluco-oligosaccharides were intraperitoneally injected, contained curcumin at 116 ng/1 g of tissue of brain, indicating that curcumin modified with gluco-oligosaccharides residues can smoothly cross the BBB in mouse brain. The brain samples of mice, which were treated with curcumin monosaccharide or curcumin itself, contained curcumin at 18 ng and 0 ng per 1 g of tissue of brain, respectively. On the other hand, after the administration of curcumin gluco-oligosaccharides to C57131, mouse with a large tumor for 5 days, the tumor disappeared.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] The blood-brain barrier and brain drug delivery
    Koziara, J. M.
    Lockman, P. R.
    Allen, D. D.
    Mumper, R. J.
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2006, 6 (9-10) : 2712 - 2735
  • [2] Drug Delivery across the Blood-Brain Barrier
    Khawli, Leslie A.
    Prabhu, Saileta
    MOLECULAR PHARMACEUTICS, 2013, 10 (05) : 1471 - 1472
  • [3] Drug delivery across the blood-brain barrier
    Hartz, AMS
    Bauer, B
    Baehr, CH
    Miller, DS
    Fricker, G
    CURRENT NANOSCIENCE, 2005, 1 (03) : 203 - 209
  • [4] The Blood-Brain Barrier and Drug Delivery
    Olbricht, William
    CHEMICAL ENGINEERING PROGRESS, 2013, 109 (03) : 31 - 34
  • [5] Modulation of the Blood-Brain Barrier for Drug Delivery to Brain
    Han, Liang
    PHARMACEUTICS, 2021, 13 (12)
  • [6] Drug delivery to brain via the blood-brain barrier
    Scherrmann, JM
    VASCULAR PHARMACOLOGY, 2002, 38 (06) : 349 - 354
  • [7] CSF, blood-brain barrier, and brain drug delivery
    Pardridge, William M.
    EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (07) : 963 - 975
  • [8] Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials
    Tsou, Yung-Hao
    Zhang, Xue-Qing
    Zhu, He
    Syed, Sahla
    Xu, Xiaoyang
    SMALL, 2017, 13 (43)
  • [9] Drug transfer across the blood-brain barrier and improvement of brain delivery
    Jolliet-Riant, P
    Tillement, JP
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (01) : 16 - 26
  • [10] Advanced Blood-Brain Barrier Drug Delivery
    Pardridge, William M.
    PHARMACEUTICS, 2023, 15 (01)